Roche Expands Digital Pathology Platform with AI-Driven Algorithms
Roche’s navify digital pathology enterprise software now integrates a range of AI-driven algorithms, enabling enhanced cancer diagnostics.
Read MorePosted by Andy Lundin | Sep 17, 2024 | Digital Pathology |
Roche’s navify digital pathology enterprise software now integrates a range of AI-driven algorithms, enabling enhanced cancer diagnostics.
Read MorePosted by Andy Lundin | Sep 13, 2024 | Digital Pathology |
Qritive has partnered with Roche to integrate its AI-powered cancer diagnostic tools with the Roche navify Digital Pathology platform.
Read MorePosted by Chris Wolski | Sep 10, 2024 | Prostate |
A new prostate cancer screening method could help better predict which patients need to undergo a biopsy, reducing unnecessary procedures.
Read MorePosted by Andy Lundin | Sep 5, 2024 | Breast, Digital Pathology |
Ibex has introduced advancements to its AI-powered platform, enhancing breast cancer diagnostics, improving algorithm accuracy, and more.
Read MorePosted by Andy Lundin | Sep 4, 2024 | Cancer, Histology |
A new AI model is capable of diagnosing multiple types of cancer, predicting patient survival, and identifying tumor molecular profiles.
Read More